Lee Enterprises, Incorporated (LEE)

NASDAQ: LEE · Real-Time Price · USD

4.560

-0.400 (-8.06%)

At close: Aug 1, 2025, 4:00 PM

4.600

+0.040 (0.88%)

After-hours: Aug 1, 2025, 4:10 PM EDT

CTI BioPharma Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 30, 2025	Sep '24 Sep 29, 2024	Sep '23 Sep 24, 2023	Sep '22 Sep 25, 2022	Sep '21 Sep 26, 2021	Sep '20 Sep 27, 2020	2016 - 2020
Operating Revenue	538.96	557.62	632.27	720.05	727	557.94	Upgrade
Other Revenue	52.14	53.76	58.87	60.92	67.65	60.06	Upgrade
Revenue	591.09	611.38	691.14	780.97	794.65	618	Upgrade
Revenue Growth (YoY)	-7.29%	-11.54%	-11.50%	-1.72%	28.58%	21.21%	Upgrade
Cost of Revenue	250.9	249.95	293.62	335	364.06	263.47	Upgrade
Gross Profit	340.19	361.43	397.52	445.97	430.59	354.54	Upgrade
Other Operating Expenses	304.45	305.39	317.28	340.42	332.83	259.38	Upgrade
Operating Expenses	328.91	333	347.9	376.96	375.68	295.52	Upgrade
Operating Income	11.28	28.43	49.62	69.01	54.91	59.02	Upgrade
Interest Expense	-41.12	-41.23	-41.47	-41.77	-44.77	-59.71	Upgrade
Earnings From Equity Investments	4.1	4.57	6.53	5.66	6.41	3.4	Upgrade
Other Non Operating Income (Expenses)	4.1	0.46	2.59	-0.45	-0.17	8.47	Upgrade
EBT Excluding Unusual Items	-21.65	-7.77	17.26	32.45	16.38	11.19	Upgrade
Merger & Restructuring Charges	-22.52	-19.25	-12.67	-22.72	-7.18	-9.35	Upgrade
Gain (Loss) on Sale of Assets	6.95	-	-	-	-	6.38	Upgrade
Asset Writedown	-7.76	-7.76	-7.67	-14.2	-0.98	-0.97	Upgrade
Other Unusual Items	-	3.59	-	5.27	23.83	-4.4	Upgrade
Pretax Income	-44.97	-31.18	-3.08	0.8	32.05	2.84	Upgrade
Income Tax Expense	-3.56	-7.61	-0.35	0.7	7.26	2.97	Upgrade
Earnings From Continuing Operations	-41.41	-23.57	-2.73	0.1	24.79	-0.13	Upgrade
Minority Interest in Earnings	-2.2	-2.27	-2.53	-2.11	-2.05	-1.85	Upgrade
Net Income	-43.61	-25.85	-5.27	-2.02	22.75	-1.98	Upgrade
Net Income to Common	-43.61	-25.85	-5.27	-2.02	22.75	-1.98	Upgrade
Shares Outstanding (Basic)	6	6	6	6	6	6	Upgrade
Shares Outstanding (Diluted)	6	6	6	6	6	6	Upgrade
Shares Change (YoY)	1.60%	1.31%	1.52%	-0.81%	2.32%	0.10%	Upgrade
EPS (Basic)	-7.28	-4.35	-0.90	-0.35	3.98	-0.35	Upgrade
EPS (Diluted)	-7.28	-4.35	-0.90	-0.35	3.90	-0.35	Upgrade
Free Cash Flow	-19.44	-8.09	-8.29	-4.68	42.6	41.77	Upgrade
Free Cash Flow Per Share	-3.24	-1.36	-1.41	-0.81	7.31	7.34	Upgrade
Gross Margin	57.55%	59.12%	57.52%	57.10%	54.19%	57.37%	Upgrade
Operating Margin	1.91%	4.65%	7.18%	8.84%	6.91%	9.55%	Upgrade
Profit Margin	-7.38%	-4.23%	-0.76%	-0.26%	2.86%	-0.32%	Upgrade
Free Cash Flow Margin	-3.29%	-1.32%	-1.20%	-0.60%	5.36%	6.76%	Upgrade
EBITDA	35.74	56.05	80.24	105.55	97.75	95.16	Upgrade
EBITDA Margin	6.05%	9.17%	11.61%	13.52%	12.30%	15.40%	Upgrade
D&A For EBITDA	24.46	27.62	30.62	36.54	42.84	36.13	Upgrade
EBIT	11.28	28.43	49.62	69.01	54.91	59.02	Upgrade
EBIT Margin	1.91%	4.65%	7.18%	8.84%	6.91%	9.55%	Upgrade
Effective Tax Rate	-	-	-	87.80%	22.64%	104.57%	Upgrade
Revenue as Reported	591.09	611.38	691.14	780.97	794.65	618	Upgrade

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q